Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ABVC BioPharma, Inc. - Common Stock (NQ:ABVC)

1.210 -0.110 (-8.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 294,890
Open 1.320
Bid (Size) 1.180 (6)
Ask (Size) 1.250 (6)
Prev. Close 1.320
Today's Range 1.180 - 1.350
52wk Range 0.4000 - 1.400
Shares Outstanding 24,420,526
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504
SILICON VALLEY, CA - May 9, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS),... 
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
+88.7%
+88.7%
1 Month
+35.2%
+35.2%
3 Month
+164.2%
+164.2%
6 Month
+123.1%
+123.1%
1 Year
+9.0%
+9.0%

More News

Read More
ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan
Via NewMediaWire
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan
Via TheNewswire.com
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
UPDATE: ABVC BioPharma Announces 2024 Financial Results
Via NewMediaWire
ABVC BioPharma Announces 2024 Financial Results
Via NewMediaWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Which stocks are moving on Monday?
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session.
Via Chartmill
ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
Via NewMediaWire
Topics Economy
Exposures Supply Chain
ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Top stock movements in today's session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth Potential
Via NewMediaWire
ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth Potential
Via TheNewswire.com
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
Via NewMediaWire
Topics Economy
Exposures Supply Chain
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Which stocks have an unusual volume on Monday?
Via Chartmill
On Friday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
Via TheNewswire.com
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
Via NewMediaWire
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence

Frequently Asked Questions

Is ABVC BioPharma, Inc. - Common Stock publicly traded?
Yes, ABVC BioPharma, Inc. - Common Stock is publicly traded.
What exchange does ABVC BioPharma, Inc. - Common Stock trade on?
ABVC BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ABVC BioPharma, Inc. - Common Stock?
The ticker symbol for ABVC BioPharma, Inc. - Common Stock is ABVC on the Nasdaq Stock Market
What is the current price of ABVC BioPharma, Inc. - Common Stock?
The current price of ABVC BioPharma, Inc. - Common Stock is 1.210
When was ABVC BioPharma, Inc. - Common Stock last traded?
The last trade of ABVC BioPharma, Inc. - Common Stock was at 05/09/25 04:00 PM ET
What is the market capitalization of ABVC BioPharma, Inc. - Common Stock?
The market capitalization of ABVC BioPharma, Inc. - Common Stock is 29.55M
How many shares of ABVC BioPharma, Inc. - Common Stock are outstanding?
ABVC BioPharma, Inc. - Common Stock has 30M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.